Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ko, JH | - |
dc.contributor.author | Kim, WH | - |
dc.contributor.author | Chung, CC | - |
dc.date.accessioned | 2022-12-21T11:55:26Z | - |
dc.date.available | 2022-12-21T11:55:26Z | - |
dc.date.created | 2022-08-26 | - |
dc.date.issued | 2006-03 | - |
dc.identifier.issn | 0018-9294 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/181721 | - |
dc.description.abstract | This paper presents dynamic programming therapy to reduce medication and establish long-term immune response against HIV-infection. Understanding HIV-related immune system control enables better HIV therapy without using full-treatments. Discrete regimen and continuous regimen characteristics are compared. Controllability of HIV-related immune system is analyzed for better understanding of optimal control in HIV therapy. Using optimal control provides more effective therapy than the full treatment without interruption in terms of controllability analysis. Case studies indicated the proposed therapy induces long-term nonprogression while preserving high CD4 T-helper cell count and low virus load in HIV-infected patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC | - |
dc.title | Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Chung, CC | - |
dc.identifier.doi | 10.1109/TBME.2005.869651 | - |
dc.identifier.scopusid | 2-s2.0-33344455191 | - |
dc.identifier.wosid | 000235560400003 | - |
dc.identifier.bibliographicCitation | IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, v.53, no.3, pp.380 - 386 | - |
dc.relation.isPartOf | IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING | - |
dc.citation.title | IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING | - |
dc.citation.volume | 53 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 380 | - |
dc.citation.endPage | 386 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.subject.keywordPlus | DRUG-THERAPY | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | FUTURE | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordAuthor | controllability | - |
dc.subject.keywordAuthor | dynamic programming | - |
dc.subject.keywordAuthor | HIV | - |
dc.subject.keywordAuthor | MPC | - |
dc.subject.keywordAuthor | optimal control | - |
dc.subject.keywordAuthor | STI | - |
dc.identifier.url | https://ieeexplore.ieee.org/document/1597488 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.